Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
Circulation
    October 2026
  1. LINDBERG F, Lund LH
    Approach to Heart Failure With Mildly Reduced Left Ventricular Ejection Fraction.
    Circulation. 2026;154:1537-1540.
    >> Share

  2. CHAIKIJURAJAI T, Reddy YNV, Harada T, Naser JA, et al
    Prominent V Waves Augment Right Ventricular Afterload Independent of the Lung Vessels in Heart Failure: Implications for Clinical Assessment of Pulmonary Vascular Disease.
    Circulation. 2026 Oct 11:10.1161/CIRCULATIONAHA.126.081799.
    >> Share

  3. KOMURO J, Ko T, Ito M, Hashimoto H, et al
    Mast Cell-Derived IL-4 Induces Pathogenic Cardiac Fibroblasts in Heart Failure.
    Circulation. 2026;154:1378-1381.
    >> Share

    September 2026
  4. YU B, Ren L, Liu Y, Tu C, et al
    Modeling Heart Failure With Preserved Ejection Fraction Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Circulation. 2026;154:1261-1264.
    >> Share

  5. GEAGEA M, Kozaily E, Buchanan CJ, Wilcox JE, et al
    Under Pressure: When Heart Failure Isn't Full.
    Circulation. 2026;154:1277-1285.
    >> Share

  6. CIHAKOVA D, Welsh RA
    CD8 T Cells Derived Granzyme B Mediated Heart Failure After Checkpoint Blockade.
    Circulation. 2026;154:1258-1260.
    >> Share

  7. WU MM, Sun Y, Zhang Y, Yang YC, et al
    Inhibition of Programmed Cell Death-1 in Cytotoxic CD8(+) T Cells Exacerbates Pressure Overload-Induced Cardiac Injury.
    Circulation. 2026;154:1238-1257.
    >> Share

  8. JAESCHKE L, Kocana C, Chitroceanu AM, Winkler A, et al
    Myeloid Cell Expansion Propels Right Ventricular Dysfunction in HFpEF Through Sterile Inflammation.
    Circulation. 2026;154:1200-1220.
    >> Share

  9. LV Y, Sha Z, Peng S, Duan Z, et al
    Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis.
    Circulation. 2026 Sep 22. doi: 10.1161/CIRCULATIONAHA.126.080625.
    >> Share

  10. PURI K, Allen K, Jentzer J, Soderstrom R, et al
    Surviving Pediatric Cardiogenic Shock: Clinical Approach, Improving Outcomes, and Future Directions: A Scientific Statement From the American Heart Association.
    Circulation. 2026;154:e374-e392.
    >> Share

    August 2026
  11. GUPTA R
    Multimodal Collaborative Care for Heart Failure in Resource-Limited Settings.
    Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082774.
    >> Share

  12. KITKO LA
    Advancing the Science of Nurse-Led Collaborative Care in Heart Failure.
    Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082775.
    >> Share

  13. JEEMON P, Ganapathi S, Anikkady N, Ismail S, et al
    Effectiveness of Nurse-Coordinated, Digital-Supported Collaborative Care Model in Reducing Hospital Stay and Mortality Among Patients With Heart Failure: TIME-HF Cluster RCT India.
    Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082490.
    >> Share

  14. JANUZZI JL JR, Rosenmeier JB, Ely Pizzato P, Quintana-Hayashi MP, et al
    Oral Relaxin Receptor Agonist AZD5462 in Participants With Chronic Heart Failure: Primary Results From the LUMINARA Trial.
    Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082763.
    >> Share

  15. WICKS EC, Velmurugan S
    Using the New Universal Definition of Heart Failure in Clinical Practice.
    Circulation. 2026;154:680-682.
    >> Share

  16. TROMP J
    Preventable Majority: Global Health Implications of the Second Universal Definition of Heart Failure.
    Circulation. 2026;154:683-685.
    >> Share

  17. MORA-AYESTARAN N, Ramos-Lopez N, Ochoa JP, Ibargoyen AY, et al
    Left Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy.
    Circulation. 2026;154:440-453.
    >> Share

    July 2026
  18. DEWANJEE A, Lamberson V, Yang Y, Giugni FR, et al
    Association of Pulmonary Vascular Remodeling With Cardiac Structure and Function, Pulmonary Pressure, and Heart Failure in Late Life: The Atherosclerosis Risk in Communities (ARIC) Study.
    Circulation. 2026 Jul 21:10.1161/CIRCULATIONAHA.125.077856.
    >> Share

  19. PACKER M, Schiattarella GG, Petrie MC, Burkhoff D, et al
    Does Characterization of Phenotypic Heterogeneity Provide Mechanistic Insights or Influence the Response to Treatment? Experience in Positive and Neutral Trials in Patients With Heart Failure and a Preserved Ejection Fraction.
    Circulation. 2026;154:271-287.
    >> Share

  20. WU M, Tan J, Zhou W, Zhang Z, et al
    SIRT5 Ameliorates Cardiac Fibrosis via PCK2 Desuccinylation-Mediated Metabolic Reprogramming in Cardiac Fibroblasts.
    Circulation. 2026;154:243-264.
    >> Share

    June 2026
  21. WALSH MN, Kober L, Sliwa K, Adamo M, et al
    AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).
    Circulation. 2026 Jun 29. doi: 10.1161/CIR.0000000000001455.
    >> Share

  22. ADEDINSEWO DA, Brown HL, Hameed AB, McNamara D, et al
    Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Jun 24. doi: 10.1161/CIR.0000000000001450.
    >> Share

  23. LEWSEY SC, Martyn T, Blumer V, Brownell NK, et al
    Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Jun 18. doi: 10.1161/CIR.0000000000001437.
    >> Share

  24. RUBERTO FP, Lee CJM, Ackers-Johnson M, Sridharan P, et al
    Loss of STMP1 Perturbs Mitochondrial Cristae and Drives Cellular Inflammation and Heart Failure.
    Circulation. 2026 Jun 10. doi: 10.1161/CIRCULATIONAHA.124.073677.
    >> Share

  25. CHEN Q, Wang X, Yin Z, Liu S, et al
    Alternative Splicing of TPM1 Mediated by SRPK3 Drives Cardiac Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2026 Jun 9. doi: 10.1161/CIRCULATIONAHA.125.079124.
    >> Share

  26. NDUMELE CE, Rodriguez F, Dixon DL, Khan SS, et al
    2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidel
    Circulation. 2026 Jun 9. doi: 10.1161/CIR.0000000000001453.
    >> Share

  27. KHAN SS, Bhave N, Blumenthal RS, Coresh J, et al
    Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Ca
    Circulation. 2026 Jun 9. doi: 10.1161/CIR.0000000000001447.
    >> Share

  28. AGGARWAL R, Oseran AS, Manrai AK, Marinacci LX, et al
    Performance of Local Large Language Models for Adjudicating Heart Failure Hospitalizations.
    Circulation. 2026;153:1785-1787.
    >> Share

  29. QIN Z, Fu C, Xie J
    Letter by Qin et al Regarding Article "Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitaliz
    Circulation. 2026;153:e1363-e1364.
    >> Share

  30. BIFFI M, Rovaris G, Pisano ECL, Calvi V, et al
    Role of Atrial Pacing Support in Cardiac Resynchronization Therapy: A Noninferiority Randomized Trial.
    Circulation. 2026;153:1707-1718.
    >> Share

    May 2026
  31. GU H, Wen J, Liu Y, Xue Y, et al
    SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure.
    Circulation. 2026 May 22. doi: 10.1161/CIRCULATIONAHA.126.079823.
    >> Share

  32. CHEN YY, Borkowski P, Biavati L, Nazarenko N, et al
    Multidimensional Social Adversity and Mortality in People With HIV Infection and Heart Failure: Insights from NYC Health + Hospitals HIV-Heart Failure Cohort.
    Circulation. 2026 May 19. doi: 10.1161/CIRCULATIONAHA.126.078897.
    >> Share

  33. SARMA S, Chin KM
    Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection Fraction.
    Circulation. 2026;153:1460-1462.
    >> Share

  34. DHONT S, Moura Ferreira S, Galloo X, Martens P, et al
    Angiotensin Receptor Neprilysin Inhibitor in Heart Failure with Preserved Ejection Fraction and Secondary Mitral Regurgitation: the PRAISE-MR Randomized Trial.
    Circulation. 2026 May 9. doi: 10.1161/CIRCULATIONAHA.126.080833.
    >> Share

  35. LI R, Tang Y, Ding Y, Hu P, et al
    GPRASP1 Safeguards Endothelial Aspartate Metabolism to Prevent Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
    Circulation. 2026 May 7. doi: 10.1161/CIRCULATIONAHA.126.079030.
    >> Share

    April 2026
  36. BATRA J, Einstein AJ, Sayer G, Takeda K, et al
    When the Heart Cannot Fill: An Unusual Cause of Congestive Heart Failure.
    Circulation. 2026;153:1255-1260.
    >> Share

  37. INOUE K, Kazi DS
    GLP-1RA Use and the Risk of Heart Failure in Patients With Diabetes: Association or Causation?
    Circulation. 2026;153:1101-1103.
    >> Share

  38. LANDSTEINER I, Stolze LK, Peterson TE, Perry A, et al
    Multi-Organ Physiologic Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure with Preserved Ejection Fraction.
    Circulation. 2026 Apr 7. doi: 10.1161/CIRCULATIONAHA.125.077579.
    >> Share

  39. CABRERA AG, Price JF, Hong BJ, Jeewa A, et al
    Evaluation and Management of the Child With Acute Decompensated Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Apr 6. doi: 10.1161/CIR.0000000000001428.
    >> Share

  40. PULLAMSETTI SS, Vanderpool RR, de Man F, de Jesus Perez VA, et al
    Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Apr 2. doi: 10.1161/CIR.0000000000001422.
    >> Share

  41. HOJBJERG LASSEN MC, Ostrominski JW, Claggett BL, Ndumele CE, et al
    Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study.
    Circulation. 2026 Apr 1. doi: 10.1161/CIRCULATIONAHA.125.077894.
    >> Share

    March 2026
  42. PEIRO-AVENTIN B, Revuelta-Lopez E, Brandao M, Nunez J, et al
    MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac Amyloidosis.
    Circulation. 2026 Mar 31. doi: 10.1161/CIRCULATIONAHA.125.077833.
    >> Share

  43. MENG C, Wang Y, Miao G
    Letter by Meng et al Regarding Article, "An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure".
    Circulation. 2026;153:e1058.
    >> Share

  44. XIONG J, Zhang B
    Response by Xiong and Zhang to Letter Regarding Article, "An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure".
    Circulation. 2026;153:e1059-e1060.
    >> Share

  45. VEMULAPALLI S, Pena Guerra K, Wojdyla D, Jones WS, et al
    Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials.
    Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080072.
    >> Share

  46. GOMBERG-MAITLAND M, Tedford RJ, Langleben D, Rosenkranz S, et al
    Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study.
    Circulation. 2026 Mar 29. doi: 10.1161/CIRCULATIONAHA.126.079918.
    >> Share

  47. LI S, Gupta K, Ranka RK, Lu AJ, et al
    Recovery From Heart Failure: Microvascular Mechanisms.
    Circulation. 2026 Mar 25. doi: 10.1161/CIRCULATIONAHA.125.078996.
    >> Share

  48. TARABANIS C, Khurshid S, Givertz MM
    Revisiting Digitalis in Heart Failure: Lessons From DIGIT-HF and Beyond.
    Circulation. 2026;153:795-797.
    >> Share

  49. LEI J, Zhang F, Wang J
    Correction to: Letter by Lei et al Regarding Article, "A Randomized Controlled Trial of Thoracentesis in Acute Heart Failure".
    Circulation. 2026;153:e934.
    >> Share

  50. ZHANG Y, Bonnet S, Provencher S, Piao J, et al
    A Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension.
    Circulation. 2026 Mar 9. doi: 10.1161/CIRCULATIONAHA.125.078674.
    >> Share

  51. MARTIN TG, Hunt DR, Ebmeier CC, Dhand AP, et al
    Myocardial Recovery With Mechanical Circulatory Support Is Linked to Alternative Splicing and Subcellular Localization of CAMK2D.
    Circulation. 2026;153:673-687.
    >> Share

  52. ZHANG Z, Zhu D, Liu C, Gan L, et al
    Small Extracellular Vesicle External Surface Adiponectin-Mediated Adipocytes/Cardiomyocytes Communication in Diabetic Ischemic Heart Failure.
    Circulation. 2026 Mar 2. doi: 10.1161/CIRCULATIONAHA.125.076372.
    >> Share

    February 2026
  53. XU Y, Huang T, Zhang Y, Ji D, et al
    Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation.
    Circulation. 2026 Feb 24. doi: 10.1161/CIRCULATIONAHA.125.075157.
    >> Share

  54. MALLOY CR, Cheeran D
    Inhibiting Fatty Acid Oxidation With a Mitotrope in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2026;153:564-566.
    >> Share

  55. HUNDERTMARK MJ, Birkhoelzer SM, Portwood C, Siu AG, et al
    IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.
    Circulation. 2026;153:550-563.
    >> Share

  56. REDDY YNV, Frantz RP, Miranda WR, Asokan AK, et al
    Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.
    Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.077606.
    >> Share

  57. PAN T, Liu T, Jiang C, Yu X, et al
    Insulin Resistance Compromises the Pentose Phosphate Pathway and Impairs Left Ventricular Assist Device-Mediated Myocardial Recovery in Obese Patients with Heart Failure.
    Circulation. 2026 Feb 6. doi: 10.1161/CIRCULATIONAHA.124.072850.
    >> Share

    January 2026
  58. FILIPP M, Ge ZD, DeBerge M, Lantz C, et al
    Correction to: Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote Heart Failure With Preserved Ejection Fraction.
    Circulation. 2026;153:e10.
    >> Share

  59. WANG H, Wang J, Zhu M, Jin L, et al
    GRSF1 Protects Against Heart Failure by Maintaining BCAA Homeostasis.
    Circulation. 2026 Jan 5. doi: 10.1161/CIRCULATIONAHA.125.074700.
    >> Share

    December 2025
  60. GLARGAARD S, Thune JJ
    Response by Glargaard and Thune to Letters Regarding Article, "A Randomized Trial of Thoracentesis in Acute Heart Failure".
    Circulation. 2025;152:e472-e473.
    >> Share

  61. HARRIS BRE, Nelson DR, Kern RM
    Letter by Harris et al Regarding Article, "A Randomized Controlled Trial of Thoracentesis in Acute Heart Failure".
    Circulation. 2025;152:e471.
    >> Share

  62. BOCCATONDA A, D'Ardes D, Cipollone F
    Letter by Boccatonda et al Regarding Article, "A Randomized Controlled Trial of Thoracentesis in Acute Heart Failure".
    Circulation. 2025;152:e469-e470.
    >> Share

  63. LEI J, Zhang F, Wang J
    Letter by Lei et al Regarding Article, "A Randomized Controlled Trial of Thoracentesis in Acute Heart Failure".
    Circulation. 2025;152:e467-e468.
    >> Share

    November 2025
  64. MARGONATO D, Enriquez-Sarano M, Nishihara T, Phichaphop A, et al
    Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance.
    Circulation. 2025 Nov 12. doi: 10.1161/CIRCULATIONAHA.125.074862.
    >> Share

  65. LIU X, Wang Q, Li X, Yang Y, et al
    Correction to: Fast Degradation of MecciRNAs by SUPV3L1/ELAC2 Provides a Novel Opportunity to Tackle Heart Failure With Exogenous MecciRNA.
    Circulation. 2025;152:e404.
    >> Share

  66. ZHAO N, Li X, Wang L
    Letter by Zhao et al Regarding Article, "Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity".
    Circulation. 2025;152:e372-e373.
    >> Share

  67. ZILE MR, Borlaug BA, Kramer CM, Packer M, et al
    Response by Zile et al to Letter Regarding Article, "Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity".
    Circulation. 2025;152:e374-e375.
    >> Share

  68. TARUYA A, Ota S, Shiono Y, Yamano T, et al
    Dapagliflozin Reduces Epicardial Adipose Tissue and Myocardial Fibrosis in Subclinical Heart Failure: The DAPA-EAT Trial.
    Circulation. 2025 Nov 9. doi: 10.1161/CIRCULATIONAHA.125.077630.
    >> Share

  69. OKOH AK, Appiah LT, Wiafe YA, Amponsah MK, et al
    AI-Enabled Digital Auscultation for Detecting Heart Failure with Reduced Ejection Fraction in Sub-Saharan Africa: The DAMSUN-HF Study.
    Circulation. 2025 Nov 8. doi: 10.1161/CIRCULATIONAHA.125.078246.
    >> Share

  70. PACKER M
    Conceptual Models to Explain Heart Failure With a Preserved Ejection Fraction: a Tale of Futility, Frustration, and Perhaps, Fruition.
    Circulation. 2025 Nov 8. doi: 10.1161/CIRCULATIONAHA.125.078115.
    >> Share

  71. FU K, Xu B, Zhong L
    Letter by Fu et al Regarding Article, "Cardiac Reprogramming and Gata4 Overexpression Reduce Fibrosis and Improve Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction".
    Circulation. 2025;152:1318-1319.
    >> Share

  72. YAMADA Y, Sadahiro T, Ieda M
    Response by Yamada et al to Letter Regarding Article, "Cardiac Reprogramming and Gata4 Overexpression Reduce Fibrosis and Improve Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction".
    Circulation. 2025;152:1320-1321.
    >> Share

  73. LI X, Raisinghani N, Gallinat A, Santos-Gallego CG, et al
    Circulating Extracellular Vesicles in the Pathogenesis of Heart Failure in Patients with Chronic Kidney Disease.
    Circulation. 2025 Nov 3. doi: 10.1161/CIRCULATIONAHA.125.075579.
    >> Share

    October 2025
  74. LUO S, Xu Y, Zhang S, Rooney MR, et al
    Two-Week Atrial Fibrillation Burden and Incident Heart Failure Among Older Individuals in the ARIC Study.
    Circulation. 2025;152:1037-1039.
    >> Share

  75. CAMPAIN J, Griskowitz C, Newlands C, Claggett BL, et al
    Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial.
    Circulation. 2025;152:990-1002.
    >> Share

  76. GASPERETTI A, Muller SA, Peretto G, Asatryan B, et al
    Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants.
    Circulation. 2025;152:978-989.
    >> Share

    September 2025
  77. REDEL-TRAUB G, Marx SO, Marks AR
    Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review.
    Circulation. 2025;152:957-970.
    >> Share

  78. PAN T, Lu L, Youker K, Shiau CK, et al
    Single-Cell Splicing Isoform Atlas of the Adult Human Heart and Heart Failure.
    Circulation. 2025 Sep 29. doi: 10.1161/CIRCULATIONAHA.125.074959.
    >> Share

    August 2025
  79. SOHNS C, Moersdorf M, Marrouche NF, Costard-Jaeckle A, et al
    3-Year Outcomes of Catheter Ablation in Patients with End-Stage Heart Failure and Atrial Fibrillation.
    Circulation. 2025 Aug 31. doi: 10.1161/CIRCULATIONAHA.125.075787.
    >> Share

  80. BERG DD, Patel SM, Haller PM, Cange AL, et al
    Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure.
    Circulation. 2025 Aug 29. doi: 10.1161/CIRCULATIONAHA.125.076575.
    >> Share

  81. KORNELIUS E
    Letter by Kornelius Regarding Article, "Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial".
    Circulation. 2025;152:e64.
    >> Share

  82. DOCHERTY KF, Henderson AD, Jhund PS, Solomon SD, et al
    Response by Docherty et al to Letter Regarding Article, "Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial".
    Circulation. 2025;152:e65-e66.
    >> Share

  83. XIONG J, Zhang S, Geng Z, Lin J, et al
    An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure.
    Circulation. 2025 Aug 18. doi: 10.1161/CIRCULATIONAHA.125.074845.
    >> Share

  84. KORNELIUS E
    Letter by Kornelius Regarding Article, "Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure".
    Circulation. 2025;152:e63.
    >> Share

  85. JHA AK
    Letter by Jha Regarding Article, "Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial".
    Circulation. 2025;152:e48-e49.
    >> Share

    July 2025
  86. PERGOLA V, Trancuccio A, Kukavica D, Mazzanti A, et al
    Genotype-Specific Outcomes of Desmosomal Cardiomyopathies.
    Circulation. 2025;152:233-245.
    >> Share

  87. WANG Q, Ismahil MA, Zhu Y, Rokosh G, et al
    CD206(+)IL-4Ralpha(+) Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
    Circulation. 2025;152:257-273.
    >> Share

  88. SCHUMACHER KR, Rosenthal DN, Batazzi A, Yu S, et al
    The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20-Center Retrospective Cohort Study.
    Circulation. 2025 Jul 9. doi: 10.1161/CIRCULATIONAHA.124.072961.
    >> Share

    June 2025
  89. GUO X, Huang C, Zhang L, Hu G, et al
    Lymphatic Endothelial Branched-Chain Amino Acid Catabolic Defects Undermine Cardiac Lymphatic Integrity and Drive HFpEF.
    Circulation. 2025;151:1651-1666.
    >> Share

  90. PANDEY A, Thomas T, Ji Y, Kroger B, et al
    TET2-Mutant Clonal Hematopoiesis Promotes Heart Failure With Preserved Ejection Fraction.
    Circulation. 2025;151:1622-1625.
    >> Share

  91. FONSEKA O, Raja R, Ross C, Gare SR, et al
    XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity.
    Circulation. 2025;151:1583-1605.
    >> Share

    May 2025
  92. ZHENG Y, Cao Y, Wang W, Tong Y, et al
    Dusp14-Mediated Dephosphorylation of MLKL Protects Against Cardiomyocyte Necroptosis in Hypothyroidism-Induced Heart Failure.
    Circulation. 2025 May 13. doi: 10.1161/CIRCULATIONAHA.125.074353.
    >> Share

  93. METRA M, Tomasoni D, Adamo M, Anker SD, et al
    Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions.
    Circulation. 2025;151:1342-1363.
    >> Share

  94. MICHEL LYM, Esfahani H, De Mulder D, Verdoy R, et al
    An NRF2/beta3-Adrenoreceptor Axis Drives a Sustained Antioxidant and Metabolic Rewiring Through the Pentose-Phosphate Pathway to Alleviate Cardiac Stress.
    Circulation. 2025;151:1312-1328.
    >> Share

    April 2025
  95. NAKAMORI S, Omori T, Fujimoto N, Ishida M, et al
    Interplay Between Epicardial Adipose Tissue and Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2025;151:1294-1296.
    >> Share

  96. KHAN SS, Breathett K, Braun LT, Chow SL, et al
    Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 16. doi: 10.1161/CIR.0000000000001307.
    >> Share

  97. BUTLER J, Usman MS, Gandotra C, Salman A, et al
    Patient-Reported Outcomes as End Points in Heart Failure Trials.
    Circulation. 2025;151:1111-1125.
    >> Share

  98. OMLAND T, Mills NL
    Natriuretic Peptides for the Diagnosis of Heart Failure With Preserved Ejection Fraction.
    Circulation. 2025;151:990-992.
    >> Share

  99. GLARGAARD S, Hartvig Thomsen J, Tuxen C, Lindholm MG, et al
    A Randomized Controlled Trial of Thoracentesis in Acute Heart Failure.
    Circulation. 2025 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.073521.
    >> Share

    March 2025
  100. EBERLY L, Tennison A, Morgan L, Smith M, et al
    Centering Dine (Navajo) Voices: Barriers, Facilitators, and Perceptions of Cardiac Care among Patients with Heart Failure in Rural Navajo Nation.
    Circulation. 2025 Mar 31. doi: 10.1161/CIRCULATIONAHA.124.073166.
    >> Share

  101. KAR S, Makkar RR, Whisenant BK, Hamid N, et al
    Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Trial.
    Circulation. 2025 Mar 30. doi: 10.1161/CIRCULATIONAHA.125.074536.
    >> Share

  102. CHEN L, Hu Y, Saguner AM, Bauce B, et al
    Natural History and Clinical Outcomes of Patients With DSG2/DSC2 Variant-Related Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2025 Mar 24. doi: 10.1161/CIRCULATIONAHA.124.072226.
    >> Share

  103. HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
    Correction to: Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
    Circulation. 2025;151:e763.
    >> Share

  104. BASILE C, Lindberg F, Benson L, Guidetti F, et al
    Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction.
    Circulation. 2025 Mar 17. doi: 10.1161/CIRCULATIONAHA.124.072855.
    >> Share

  105. FILIPP M, Ge ZD, DeBerge M, Lantz C, et al
    Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote Heart Failure With Preserved Ejection Fraction.
    Circulation. 2025 Mar 12. doi: 10.1161/CIRCULATIONAHA.124.070248.
    >> Share

  106. DAI H, Lu X, Zhou X
    Letter by Dai et al Regarding Article, "Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction".
    Circulation. 2025;151:e686.
    >> Share

  107. YANCY CW
    Heart Failure: A Century View, From Failure to Function.
    Circulation. 2025;151:585-588.
    >> Share

    February 2025
  108. LIU X, Wang Q, Li X, Yang Y, et al
    Fast Degradation of MecciRNAs by SUPV3L1/ELAC2 Provides a Novel Opportunity to Tackle Heart Failure With Exogenous MecciRNA.
    Circulation. 2025 Feb 20. doi: 10.1161/CIRCULATIONAHA.124.070840.
    >> Share

  109. BRAUMANN S, Macherey-Meyer S, Polzin A, Costard-Jackle A, et al
    MYSTERY-HF - Myeloperoxidase Inhibition in Patients With Heart Failure and Reduced Ejection Fraction - a Phase II Randomized Controlled Trial.
    Circulation. 2025 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.074085.
    >> Share

  110. SHEN L, Jhund PS, McMurray JJV
    Response by Shen et al to Letter Regarding Article, "Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF".
    Circulation. 2025;151:e38.
    >> Share

  111. TUNCEZ A, Gurses KM
    Letter by Tuncez and Gurses Regarding Article, "Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF".
    Circulation. 2025;151:e37.
    >> Share

    January 2025
  112. KUEHN BM
    Kidney Decline Predicts Worse Heart Failure Outcomes.
    Circulation. 2025;151:348-350.
    >> Share

  113. REDDY YNV, Tada A, Obokata M, Carter RE, et al
    Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting.
    Circulation. 2025 Jan 22. doi: 10.1161/CIRCULATIONAHA.124.072156.
    >> Share

  114. PARK SJ, Kang DH
    Response by Park and Kang to Letter Regarding Article, "Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial".
    Circulation. 2025;151:e28.
    >> Share

  115. MORDI IR, McCrimmon RJ, Lang CC
    SGLT Inhibitors in Persons With Heart Failure and Type 1 Diabetes: Filling the Therapeutic Gap.
    Circulation. 2025;151:199-201.
    >> Share

  116. WANG J, Peng Y
    Letter by Wang and Peng Regarding Article, "Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial".
    Circulation. 2025;151:e27.
    >> Share

  117. DERKS W, Rode J, Collin S, Rost F, et al
    A Latent Cardiomyocyte Regeneration Potential in Human Heart Disease.
    Circulation. 2025;151:245-256.
    >> Share

    December 2024
  118. YAMADA Y, Sadahiro T, Nakano K, Honda S, et al
    Cardiac Reprogramming and Gata4 Overexpression Reduce Fibrosis and Improve Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024 Dec 14. doi: 10.1161/CIRCULATIONAHA.123.067504.
    >> Share

  119. DOI SN, Butt JH, Thune JJ, Nielsen JC, et al
    Left Ventricular Ejection Fraction and Implantable Cardioverter-Defibrillator in Non-ischemic Heart Failure with Reduced Ejection Fraction: Insights from DANISH.
    Circulation. 2024 Dec 10. doi: 10.1161/CIRCULATIONAHA.124.071777.
    >> Share

  120. ALVAREZ-GARCIA J
    Cognitive Dysfunction in Heart Failure With Preserved Ejection Fraction: Uncovering the Consequences of an Overlooked Comorbidity.
    Circulation. 2024;150:1928-1930.
    >> Share

  121. YANG X, Zhang Z
    Letter by Yang and Zhang Regarding Article, "Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic: The PRO-HF Trial".
    Circulation. 2024;150:e468.
    >> Share

  122. SANDHU AT, Spertus JA, Heidenreich PA
    Reply by Sandhu et al to Letter Regarding Article, "Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic: The PRO-HF Trial".
    Circulation. 2024;150:e469-e470.
    >> Share

    November 2024
  123. KEHR D, Ritterhoff J, Glaser M, Jarosch L, et al
    S100A1ct: A Synthetic Peptide Derived From S100A1 Protein Improves Cardiac Performance and Survival in Preclinical Heart Failure Models.
    Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.123.066961.
    >> Share

  124. JI Y, Zhang MJ, Wang W, Norby FL, et al
    Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS.
    Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278.
    >> Share

  125. ZILE MR, Borlaug BA, Kramer CM, Baum SJ, et al
    Effects of Tirzepatide on the Clinical Trajectory of Patients with Heart Failure, a Preserved Ejection Fraction, and Obesity.
    Circulation. 2024 Nov 18. doi: 10.1161/CIRCULATIONAHA.124.072679.
    >> Share

  126. VOORRIPS SN, Westenbrink BD
    Ketone Treatment in Heart Failure With Preserved Ejection Fraction: Recharging the Heart or Reducing Filling Pressures?
    Circulation. 2024;150:1584-1587.
    >> Share

    October 2024
  127. SHEN L, Dewan P, Ferreira JP, Cunningham JW, et al
    Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.
    Circulation. 2024 Oct 21. doi: 10.1161/CIRCULATIONAHA.124.070553.
    >> Share

  128. SOHNS C, Sommer P
    Patients With Advanced Heart Failure and Atrial Fibrillation Deserve an Attempt at Catheter Ablation as First-Line Therapy.
    Circulation. 2024;150:1220-1222.
    >> Share

  129. BEDIOUNE I, Gandon-Renard M, Dessillons M, Barthou A, et al
    Essential Role of the RIalpha Subunit of cAMP-Dependent Protein Kinase in Regulating Cardiac Contractility and Heart Failure Development.
    Circulation. 2024 Oct 2. doi: 10.1161/CIRCULATIONAHA.124.068858.
    >> Share

  130. JIA K, Cheng H, Ma W, Zhuang L, et al
    RNA Helicase DDX5 Maintains Cardiac Function by Regulating CamkIIdelta Alternative Splicing.
    Circulation. 2024;150:1121-1139.
    >> Share

  131. KNEUER JM, Grajek IA, Winkler M, Erbe S, et al
    Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing.
    Circulation. 2024;150:1101-1120.
    >> Share

    September 2024
  132. DOCHERTY KF, Henderson AD, Jhund PS, Claggett BL, et al
    Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure with Mildly Reduced and Preserved Ejection Fraction: a Prespecified Analysis of The FINEARTS-HF Trial.
    Circulation. 2024 Sep 29. doi: 10.1161/CIRCULATIONAHA.124.072011.
    >> Share

  133. VADUGANATHAN M, Claggett BL, Kulac IJ, Miao ZM, et al
    Effects of the Non-Steroidal MRA Finerenone with and without Concomitant SGLT2 Inhibitor Use in Heart Failure.
    Circulation. 2024 Sep 28. doi: 10.1161/CIRCULATIONAHA.124.072055.
    >> Share

  134. SHADDY R, Burch M, Kantor PF, Solar-Yohay S, et al
    Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial.
    Circulation. 2024 Sep 25. doi: 10.1161/CIRCULATIONAHA.123.066605.
    >> Share

  135. STONE GW, Lindenfeld J, Rodes-Cabau J, Anker SD, et al
    Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial.
    Circulation. 2024 Sep 23. doi: 10.1161/CIRCULATIONAHA.124.070870.
    >> Share

  136. WANG J, Chen B, Shi Q, Ciampa G, et al
    Preventing Site-Specific Calpain Proteolysis of Junctophilin-2 Protects Against Stress-Induced Excitation-Contraction Uncoupling and Heart Failure Development.
    Circulation. 2024 Sep 18. doi: 10.1161/CIRCULATIONAHA.124.069329.
    >> Share


  137. Correction to: Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure.
    Circulation. 2024;150:e268.
    >> Share

  138. TANG WHW, Bakitas MA, Cheng XS, Fang JC, et al
    Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Sep 10. doi: 10.1161/CIR.0000000000001273.
    >> Share

  139. KOSIBOROD MN, Petrie MC, Borlaug BA
    Response by Kosiborod et al to Letter Regarding Article, "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial".
    Circulation. 2024;150:e226-e227.
    >> Share

  140. WEIR RAP
    Letter by Weir Regarding Article, "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity".
    Circulation. 2024;150:e224-e225.
    >> Share

  141. BUTT JH, McMurray JJ, Claggett BL, Jhund PS, et al
    Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant-Level Analysis of 6 Randomized Clinical Trials.
    Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071110.
    >> Share

    August 2024
  142. SOHNS C, Moersdorf M, Marrouche NF, Bergau L, et al
    Catheter Ablation in Patients with End-Stage Heart Failure and Atrial Fibrillation: Two-year Follow-up of the CASTLE-HTx Trial.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071517.
    >> Share

  143. GOPALASINGAM N, Berg-Hansen K, Christensen KH, Ladefoged BT, et al
    Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024 Aug 20. doi: 10.1161/CIRCULATIONAHA.124.069732.
    >> Share

  144. CHATUR S, Vaduganathan M, Claggett B, Solomon SD, et al
    Response by Chatur et al to Letter Regarding Article, "Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial".
    Circulation. 2024;150:e107-e108.
    >> Share

  145. WANG J
    Letter by Wang Regarding Article, "Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial".
    Circulation. 2024;150:e106.
    >> Share

  146. GREENE SJ, Butler J, Fonarow GC
    Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: 5 Core Principles.
    Circulation. 2024;150:422-424.
    >> Share

  147. NETUKA I, Tucanova Z, Ivak P, Gregor S, et al
    A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully Magnetically Levitated LVAD: The DOT-HM3 Study.
    Circulation. 2024;150:509-511.
    >> Share

  148. TADA A, Burkhoff D, Naser JA, Harada T, et al
    Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction Trial.
    Circulation. 2024 Aug 5. doi: 10.1161/CIRCULATIONAHA.124.068788.
    >> Share

    July 2024
  149. ABOUMSALLEM JP, de Boer RA
    IGFBP7: From Senescence Biomarker to a Vaccine for Heart Failure.
    Circulation. 2024;150:390-392.
    >> Share

  150. YOO SGK, Lam CSP, Sweitzer NK
    "Asian" Heart Failure.
    Circulation. 2024;150:177-179.
    >> Share

  151. WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al
    Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
    Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139.
    >> Share

  152. KATOH M, Nomura S, Yamada S, Ito M, et al
    Vaccine Therapy for Heart Failure Targeting the Inflammatory Cytokine Igfbp7.
    Circulation. 2024 Jul 11. doi: 10.1161/CIRCULATIONAHA.123.064719.
    >> Share


  153. Correction to: Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin Resistance and a Potential Therapeutic Target against Ischemic Heart Failure in Prediabetic Animals.
    Circulation. 2024;150:e63.
    >> Share

    June 2024
  154. HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
    Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
    Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.069340.
    >> Share

  155. NASER JA, Tada A, Harada T, Reddy YNV, et al
    Effects of Dapagliflozin on Body Composition and Its Relation to Hemodynamics in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024;149:2026-2028.
    >> Share

  156. DEWAN P, Shen L, Pedro Ferreira J, Jhund PS, et al
    Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF.
    Circulation. 2024 Jun 6. doi: 10.1161/CIRCULATIONAHA.124.068774.
    >> Share

    May 2024
  157. AMDANI S, Conway J, George K, Martinez HR, et al
    Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2024 May 29. doi: 10.1161/CIR.0000000000001245.
    >> Share

  158. JHENG JR, Bai Y, Noda K, Huot JR, et al
    Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624.
    >> Share

  159. CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al
    Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.
    Circulation. 2024;149:1729-1748.
    >> Share

  160. PACKER M, Anker SD, Butler J, Cleland JGF, et al
    Redefining Iron Deficiency in Patients With Chronic Heart Failure.
    Circulation. 2024 May 11. doi: 10.1161/CIRCULATIONAHA.124.068883.
    >> Share

  161. SARMA S, Dyck JRB
    Unlocking Pathways That Improve Cardiac Function in Chronic Heart Failure: Are Ketones the Key?
    Circulation. 2024;149:1490-1492.
    >> Share

  162. KANG DH, Park SJ, Shin SH, Hwang IC, et al
    Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial.
    Circulation. 2024 May 1. doi: 10.1161/CIRCULATIONAHA.124.069144.
    >> Share

    April 2024
  163. ZHANG F, Zhang L, Hu G, Chen X, et al
    Rectifying METTL4-Mediated N(6)-Methyladenine Excess in Mitochondrial DNA Alleviates Heart Failure.
    Circulation. 2024 Apr 30. doi: 10.1161/CIRCULATIONAHA.123.068358.
    >> Share

  164. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
    Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
    Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
    >> Share

  165. SWAIN L, Bhave S, Qiao X, Reyelt L, et al
    Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.
    Circulation. 2024;149:1341-1353.
    >> Share


  166. Correction to: Effects of Synchronizing Foot Strike and Cardiac Phase on Exercise Hemodynamics in Patients With Cardiac Resynchronization Therapy: A Within-Subjects Pilot Study to Fine-Tune Cardio-Locomotor Coupling for Heart Failure.
    Circulation. 2024;149:e1130.
    >> Share

  167. LI B, Liu F, Chen X, Chen T, et al
    FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis and the Mitochondrial Quality Control System.
    Circulation. 2024;149:1268-1284.
    >> Share

  168. SANDHU AT, Calma J, Skye M, Kalwani NM, et al
    Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069624.
    >> Share

  169. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
    Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
    Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
    >> Share

  170. BREATHETT K, Lewsey S, Brownell NK, Enright K, et al
    Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Apr 3. doi: 10.1161/CIR.0000000000001231.
    >> Share


  171. Correction to: INO80-Dependent Remodeling of Transcriptional Regulatory Network Underlies the Progression of Heart Failure.
    Circulation. 2024;149:e1066.
    >> Share

  172. GOKULNATH P, Spanos M, Lehmann HI, Sheng Q, et al
    Distinct Plasma Extracellular Vesicle Transcriptomes in Acute Decompensated Heart Failure Subtypes: A Liquid Biopsy Approach.
    Circulation. 2024;149:1147-1149.
    >> Share

  173. KAPELIOS CJ, Lund LH
    Preemptive Versus Urgent Heart Failure Hospitalization as a Surrogate for Mortality Risk in Heart Failure.
    Circulation. 2024;149:1062-1064.
    >> Share

    March 2024
  174. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
    Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
    Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
    >> Share

  175. JESSUP M
    A Century of Heart Failure With Reduced Ejection Fraction: Mostly Drought, Followed by Rapid Progress.
    Circulation. 2024;149:899-901.
    >> Share

  176. CLELAND JGF
    Nature and Magnitude of the Benefits of Dapagliflozin and Empagliflozin for Heart Failure.
    Circulation. 2024;149:839-842.
    >> Share

  177. VELIKANOVA D, Poyhonen P, Lehtonen J, Simonen P, et al
    End-Stage Heart Failure in Cardiac Sarcoidosis.
    Circulation. 2024;149:885-887.
    >> Share

    February 2024
  178. HOEDEMAKERS S, Pugliese NR, Stassen J, Vanoppen A, et al
    mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis.
    Circulation. 2024 Feb 27. doi: 10.1161/CIRCULATIONAHA.123.067130.
    >> Share

  179. CRESCI S, Bach RG, Saberi S, Owens AT, et al
    Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM.
    Circulation. 2024;149:498-509.
    >> Share

  180. GREEN JB, Everett BM, Ghosh A, Younes N, et al
    Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study).
    Circulation. 2024 Feb 12. doi: 10.1161/CIRCULATIONAHA.123.066604.
    >> Share

  181. JIANG Y, Gu J, Niu X, Hu J, et al
    Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure.
    Circulation. 2024 Feb 8. doi: 10.1161/CIRCULATIONAHA.123.067519.
    >> Share

  182. SANCHEZ RH, Hamdan H, Torrealba J, Grodin JL, et al
    Giants Hiding in Small Places: A Case of New Onset Heart Failure, Atrioventricular Block, and Ventricular Arrhythmias.
    Circulation. 2024;149:475-480.
    >> Share

    January 2024
  183. HERWEG B, Sharma PS, Cano O, Ponnusamy SS, et al
    Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area Pacing: Results From the I-CLAS Study.
    Circulation. 2024;149:379-390.
    >> Share

  184. SUMARSONO A, Xie L, Keshvani N, Zhang C, et al
    Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction.
    Circulation. 2024 Jan 23. doi: 10.1161/CIRCULATIONAHA.123.067489.
    >> Share

  185. BROMAN MT, Nadadur RD, Perez-Cervantes C, Burnicka-Turek O, et al
    A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory Network.
    Circulation. 2024 Jan 8. doi: 10.1161/CIRCULATIONAHA.123.066804.
    >> Share

    December 2023
  186. REN Z, Zhao W, Li D, Yu P, et al
    INO80-Dependent Remodeling of Transcriptional Regulatory Network Underlies the Progression of Heart Failure.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.065440.
    >> Share

  187. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    >> Share

  188. THOMPSON PD
    Steps May Count for More Than Just Cardiac Risk.
    Circulation. 2023;148:2017-2018.
    >> Share

  189. GOSS KN
    Preterm Birth: An Overlooked Risk Factor for Heart Failure in the Young Adult.
    Circulation. 2023;148:2005-2007.
    >> Share

  190. GOLDENBERG JR, Hays AG, Gabr RE, Sch?r M, et al
    Energetic Basis of Recovered Ejection Fraction in Human Heart Failure.
    Circulation. 2023;148:1976-1978.
    >> Share

  191. VAN DUIJVENBODEN S, Ramirez J, Orini M, Aung N, et al
    Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects.
    Circulation. 2023;148:1932-1944.
    >> Share

  192. MCMURRAY JJV, Docherty KF, de Boer RA, Hammarstedt A, et al
    Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
    Circulation. 2023 Dec 7. doi: 10.1161/CIRCULATIONAHA.123.065061.
    >> Share

    November 2023
  193. GREENE SJ, Butler J
    Expanding the Definition of Worsening Heart Failure and Recognizing the Importance of Outpatient Escalation of Oral Diuretics.
    Circulation. 2023;148:1746-1749.
    >> Share

  194. WALKER MA, Chen H, Yadav A, Ritterhoff J, et al
    Stimulates Short-Chain Dehydrogenase/Reductase Proteins to Alleviate Heart Failure Independent of Mitochondrial Protein Deacetylation.
    Circulation. 2023 Nov 15. doi: 10.1161/CIRCULATIONAHA.123.066039.
    >> Share

  195. XU W, Billon C, Li H, Wilderman A, et al
    Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.
    Circulation. 2023 Nov 14. doi: 10.1161/CIRCULATIONAHA.123.066542.
    >> Share

  196. WHELLAN DJ
    Physical Activity for Patients with Heart Failure with Reduced Ejection Fraction: Pump up the Volume.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067588.
    >> Share

  197. VETROVSKY T, Siranec M, Frybova T, Gant I, et al
    Lifestyle Walking Intervention in Patients With Heart Failure With Reduced Ejection Fraction: The WATCHFUL Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067395.
    >> Share

  198. KOSIBOROD MN, Verma S, Borlaug BA, Butler J, et al
    Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.
    Circulation. 2023 Nov 12. doi: 10.1161/CIRCULATIONAHA.123.067505.
    >> Share

  199. PATEL KV, Segar MW, Klonoff DC, Khan MS, et al
    Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: a Pooled Cohort Analysis.
    Circulation. 2023 Nov 11. doi: 10.1161/CIRCULATIONAHA.123.067530.
    >> Share

  200. KHAN SS, Coresh J, Pencina MJ, Ndumele CE, et al
    Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Nov 10. doi: 10.1161/CIR.0000000000001191.
    >> Share

  201. KHAN SS, Matsushita K, Sang Y, Ballew SH, et al
    Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations.
    Circulation. 2023 Nov 10. doi: 10.1161/CIRCULATIONAHA.123.067626.
    >> Share

  202. BAWASKAR P, Thomas N, Ismail KF, Guo Y, et al
    Non-ischemic or Dual Cardiomyopathy in Patients with Coronary Artery Disease.
    Circulation. 2023 Nov 6. doi: 10.1161/CIRCULATIONAHA.123.067032.
    >> Share

    October 2023
  203. ZAMANI SK, Sarma S, MacNamara JP, Hynan LS, et al
    Excess Pericardial Fat Is Related to Adverse Cardio-Mechanical Interaction in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2023;148:1410-1412.
    >> Share

  204. WAKEHAM DJ, Ivey E, Saland S, Lewis J, et al
    Effects of Synchronizing Foot Strike and Cardiac Phase on Exercise Hemodynamics in Patients With Cardiac Resynchronization Therapy: A Within-Subjects Pilot Study to Fine-Tune Cardio-Locomotor Coupling for Heart Failure.
    Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.066170.
    >> Share

  205. OSTROMINSKI JW, Vaduganathan M, Selvaraj S, Claggett BL, et al
    Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
    Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065254.
    >> Share

  206. BUTT JH, Yafasova A, Doi SN, Nielsen JC, et al
    Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial.
    Circulation. 2023;148:1179-1181.
    >> Share

    September 2023
  207. GODFREY S, Kirkpatrick JN, Kramer DB, Sulistio MS, et al
    Expanding the Paradigm for Cardiovascular Palliative Care.
    Circulation. 2023;148:1039-1052.
    >> Share

  208. PARKASH R, O'Meara E, Tang ASL
    The Role of Ablation-Based Rhythm Control in the Tangled Web of Atrial Fibrillation and Heart Failure.
    Circulation. 2023;148:933-935.
    >> Share

  209. LEBEK S, Caravia XM, Chemello F, Tan W, et al
    Elimination of CaMKIIdelta Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in Mice.
    Circulation. 2023 Sep 15. doi: 10.1161/CIRCULATIONAHA.123.065117.
    >> Share

  210. COCHRAN J, Yura Y, Thel MC, Doviak H, et al
    Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.
    Circulation. 2023 Sep 8. doi: 10.1161/CIRCULATIONAHA.123.064170.
    >> Share

  211. CHEW DS, Li Y, Bigelow R, Cowper PA, et al
    Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial.
    Circulation. 2023 Sep 6. doi: 10.1161/CIRCULATIONAHA.122.063602.
    >> Share

  212. ZHU H, Song YC, Hang PZ
    Letter by Zhu et al Regarding Article, "Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure".
    Circulation. 2023;148:855-856.
    >> Share

  213. ARONSEN JM, Skogestad J, Albert I, Melleby AO, et al
    Response by Aronsen et al to Letter Regarding Article, "Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure".
    Circulation. 2023;148:857-858.
    >> Share

    August 2023
  214. HEIDENREICH P
    What Is a Normal Left Ventricular Ejection Fraction?
    Circulation. 2023;148:750-752.
    >> Share

  215. CHATUR S, Vaduganathan M, Claggett BL, Cunningham JW, et al
    Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
    Circulation. 2023 Aug 26. doi: 10.1161/CIRCULATIONAHA.123.066506.
    >> Share

  216. PACKER M, Butler J, Zeller C, Pocock SJ, et al
    Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure.
    Circulation. 2023 Aug 24. doi: 10.1161/CIRCULATIONAHA.123.065748.
    >> Share


  217. Correction to: Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?
    Circulation. 2023;148:e7.
    >> Share

  218. SARMA S, Levine BD
    Response by Sarma and Levine to Letters Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?".
    Circulation. 2023;148:620-621.
    >> Share

  219. WUSSLER D, Belkin M, Mueller C
    Letter by Wussler et al Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?".
    Circulation. 2023;148:619.
    >> Share

  220. RAGONE I, Barallobre-Barreiro J, Takov K, Theofilatos K, et al
    SERCA2a Protein Levels Are Unaltered in Human Heart Failure.
    Circulation. 2023;148:613-616.
    >> Share

  221. DIMOPOULOS S, Nanas S
    Letter by Dimopoulos and Nanas Regarding Article, "Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?".
    Circulation. 2023;148:617-618.
    >> Share

  222. BORLAUG BA, Reddy YNV, Braun A, Sorimachi H, et al
    Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.
    Circulation. 2023 Aug 3. doi: 10.1161/CIRCULATIONAHA.123.065134.
    >> Share

    July 2023
  223. PACKER M, Wilcox CS, Testani JM
    Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes.
    Circulation. 2023;148:354-372.
    >> Share

  224. MENTIAS A, Mujahid MS, Sumarsono A, Nelson RK, et al
    Historical Redlining, Socioeconomic Distress, and Risk of Heart Failure Among Medicare Beneficiaries.
    Circulation. 2023;148:210-219.
    >> Share

  225. WATSON WD, Green PG, Lewis AJM, Arvidsson P, et al
    Retained Metabolic Flexibility of the Failing Human Heart.
    Circulation. 2023;148:109-123.
    >> Share

  226. GHADIMI K, Cappiello JL, Wright MC, Levy JH, et al
    Inhaled Epoprostenol Compared With Nitric Oxide for Right Ventricular Support After Major Cardiac Surgery.
    Circulation. 2023 Jul 4. doi: 10.1161/CIRCULATIONAHA.122.062464.
    >> Share

    June 2023
  227. KONDO T, Dewan P, Anand IS, Desai AS, et al
    Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
    Circulation. 2023 Jun 27. doi: 10.1161/CIRCULATIONAHA.122.063642.
    >> Share

  228. HITSUMOTO T, Tsukamoto O, Matsuoka K, Li J, et al
    Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin.
    Circulation. 2023;147:1902-1918.
    >> Share

    May 2023
  229. TANG Y, Feng M, Su Y, Ma T, et al
    Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy.
    Circulation. 2023;147:1684-1704.
    >> Share

  230. GREENE SJ, Velazquez EJ, Anstrom KJ, Clare RM, et al
    Effect of Torsemide vs Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Circulation. 2023 May 22. doi: 10.1161/CIRCULATIONAHA.123.064842.
    >> Share

  231. JANI V, Aslam MI, Fenwick AJ, Ma W, et al
    Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure With Pulmonary Hypertension.
    Circulation. 2023 May 17. doi: 10.1161/CIRCULATIONAHA.123.064717.
    >> Share

  232. GUPTA K, Spertus JA, Birmingham M, Gosch KL, et al
    Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.
    Circulation. 2023 May 16. doi: 10.1161/CIRCULATIONAHA.122.063263.
    >> Share

  233. SATTAR N, McMurray J, Boren J, Rawshani A, et al
    Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
    Circulation. 2023 May 8. doi: 10.1161/CIRCULATIONAHA.122.063374.
    >> Share

    April 2023
  234. HUNDERTMARK MJ, Adler A, Antoniades C, Coleman R, et al
    Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
    Circulation. 2023 Apr 18. doi: 10.1161/CIRCULATIONAHA.122.062021.
    >> Share

  235. BUTLER J, Talha KM, Fonarow GC
    STRONG-HF and Implementing Heart Failure Therapies: Godspeed ... With Care.
    Circulation. 2023;147:1189-1191.
    >> Share

  236. FILIPPATOS G, Ponikowski P, Farmakis D, Anker SD, et al
    Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.
    Circulation. 2023 Apr 13. doi: 10.1161/CIRCULATIONAHA.122.060757.
    >> Share

  237. ERN YEOH S, Docherty KF, Campbell RT, Jhund PS, et al
    Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.
    Circulation. 2023 Apr 11. doi: 10.1161/CIRCULATIONAHA.122.063327.
    >> Share

  238. MENTIAS A, Peterson ED, Keshvani N, Kumbhani DJ, et al
    Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure.
    Circulation. 2023;147:1121-1133.
    >> Share


  239. Correction to: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2023;147:e674.
    >> Share

  240. BUTT JH, Solomon SD, McMurray JJV
    Response by Butt et al to Letter Regarding Article, "Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial".
    Circulation. 2023;147:1119-1120.
    >> Share

  241. WONG EKC, Demers C
    Letter by Wong and Demers Regarding Article, "Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial".
    Circulation. 2023;147:1118.
    >> Share

    March 2023
  242. SACHDEV V, Sharma K, Keteyian SJ, Alcain CF, et al
    Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2023 Mar 21. doi: 10.1161/CIR.0000000000001122.
    >> Share

  243. SELVARAJ S, Kosiborod MN, Shah SH
    Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".
    Circulation. 2023;147:922-923.
    >> Share

  244. TACHIBANA S, Yu NK, Li R, Fernandez-Costa C, et al
    Perm1 Protects the Heart From Pressure Overload-Induced Dysfunction by Promoting Oxidative Metabolism.
    Circulation. 2023;147:916-919.
    >> Share

  245. MONZO L, Melenovsky V
    Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".
    Circulation. 2023;147:920-921.
    >> Share

  246. MENG Z, Zhang Z, Zhao J, Liu C, et al
    Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin Resistance and a Potential Therapeutic Target Against Ischemic Heart Failure in Prediabetic Animals.
    Circulation. 2023 Mar 8. doi: 10.1161/CIRCULATIONAHA.122.063073.
    >> Share

  247. KUEHN BM
    Collaborative Care Model Helps Patients With Heart Failure Meet End-of-Life Goals.
    Circulation. 2023;147:841-842.
    >> Share

  248. FRIEDMAN DJ, Al-Khatib SM, Dalgaard F, Fudim M, et al
    Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials.
    Circulation. 2023;147:812-823.
    >> Share

  249. SKOGESTAD J, Albert I, Hougen K, Lothe GB, et al
    Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure.
    Circulation. 2023 Mar 6. doi: 10.1161/CIRCULATIONAHA.121.054168.
    >> Share

  250. KONDO T, Jering KS, Borleffs CJW, de Boer RA, et al
    Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
    Circulation. 2023 Mar 6. doi: 10.1161/CIRCULATIONAHA.122.062918.
    >> Share

  251. HAHN VS, Petucci C, Kim MS, Bedi KC Jr, et al
    Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction.
    Circulation. 2023 Mar 1. doi: 10.1161/CIRCULATIONAHA.122.061846.
    >> Share

    February 2023
  252. LEYVA F, Israel CW, Singh J
    Declining Risk of Sudden Cardiac Death in Heart Failure: Fact or Myth?
    Circulation. 2023;147:759-767.
    >> Share

    December 2022
  253. SHELBAYA K, Claggett B, Dorbala P, Skali H, et al
    Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061396.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016